Background
Methods
Statistics
Results
Baseline characteristics
Rutherford grade 5 | Rutherford grade 6 | |||||||
---|---|---|---|---|---|---|---|---|
DM+ | DM− | All | P | DM+ | DM− | All | P | |
Patients, n (%) | 3061 (44.3) | 3855 (55.7) | 6916 (100.0) | 4108 (48.8) | 4308 (51.2) | 8416 (100.0) | ||
Male sex (%) | 1795 (58.6) | 1708 (44.3) | 3503 (50.7) | <0.001
| 2551 (62.1) | 2148 (49.9) | 4699 (55.8) | <0.001
|
Age, mean ± SD | 73.8 ± 10.8 | 77.0 ± 11.2 | 75.6 ± 11.1 | <0.001
| 73.3 ± 11.2 | 76.5 ± 12.1 | 74.9 ± 11.8 | <0.001
|
Hypertension (%) | 2172 (71.0) | 2514 (65.2) | 4686 (67.8) | <0.001
| 2860 (69.9) | 2577 (59.8) | 5437 (64.6) | <0.001
|
Obesity (%) | 361 (11.8) | 186 (4.8) | 547 (7.9) | <0.001
| 427 (10.4) | 178 (4.1) | 605 (7.2) | <0.001
|
Dyslipidemia (%) | 834 (27.2) | 836 (21.7) | 1670 (24.1) | <0.001
| 922 (22.4) | 752 (17.5) | 1674 (19.9) | <0.001
|
Smoking (%) | 140 (4.6) | 293 (7.6) | 433 (6.3) | <0.001
| 180 (4.4) | 328 (7.6) | 508 (6.0) | <0.001
|
CKD (%) | 1179 (38.5) | 960 (24.9) | 2139 (30.9) | <0.001
| 1637 (39.8) | 1160 (26.9) | 2797 (33.2) | <0.001
|
CAD (%) | 884 (28.9) | 851 (22.1) | 1735 (25.1) | <0.001
| 1218 (29.6) | 974 (22.6) | 2192 (26.0) | <0.001
|
CHF (%) | 512 (16.7) | 551 (14.3) | 1063 (15.4) |
0.005
| 766 (18.6) | 704 (16.3) | 1470 (17.5) |
0.005
|
Malignancies (%) | 55 (1.8) | 87 (2.3) | 142 (2.1) | 0.180 | 103 (2.5) | 137 (3.2) | 240 (2.9) | 0.064 |
Treatment
Rutherford grade 5 | Rutherford grade 6 | |||||||
---|---|---|---|---|---|---|---|---|
DM+ | DM− | All | P | DM+ | DM− | All | P | |
Patients, n (%) | 3061 (44.3) | 3855 (55.7) | 6916 (100.0) | 4108 (48.8) | 4308 (51.2) | 8416 (100.0) | ||
Angiography (%) | 1471 (48.1) | 2096 (54.4) | 3567 (51.6) | <0.001
| 1982 (48.2) | 2050 (47.6) | 4032 (47.9) | 0.544 |
Any revascularization (%) | 1377 (45.0) | 2141 (55.5) | 3518 (50.9) | <0.001
| 1909 (46.5) | 2231 (51.8) | 4140 (49.2) | <0.001
|
EVR (%) | 1047 (34.2) | 1403 (36.4) | 2450 (35.4) |
0.059
| 1272 (31.0) | 1209 (28.1) | 2481 (29.5) |
0.004
|
Surgery (%) | 409 (13.4) | 903 (23.4) | 1312 (19.0) | <0.001
| 809 (19.7) | 1274 (29.6) | 2083 (24.8) | <0.001
|
TEA (% of all) (% of surgery) | 160 (5.2) (39.1)
| 354 (9.2) (39.2)
| 514 (7.4) (39.2)
| <0.001
| 287 (7.0) (35.5)
| 520 (12.1) (40.8)
| 807 (9.6) (38.7)
| <0.001
|
Bypass (% of all) (% of surgery) | 266 (8.7) (65.0)
| 550 (14.3) (60.9)
| 816 (11.8) (62.2)
| <0.001
| 532 (13.0) (65.8)
| 794 (18.4) (62.3)
| 1326 (15.8) (63.7)
| <0.001
|
ARF (%) | 61 (2.0) | 66 (1.7) | 127 (1.8) | 0.388 | 115 (2.8) | 120 (2.8) | 235 (2.8) | 0.969 |
AMI (%) | 22 (0.7) | 36 (0.9) | 58 (0.8) | 0.330 | 80 (1.9) | 67 (1.6) | 147 (1.7) | 0.170 |
Ischemic stroke (%) | 14 (0.5) | 15 (0.4) | 29 (0.4) | 0.663 | 31 (0.8) | 32 (0.7) | 63 (0.7) | 0.950 |
Infection (%) | 1082 (35.3) | 905 (23.5) | 1987 (28.7) | <0.001
| 1821 (44.3) | 1180 (27.4) | 3001 (35.7) | <0.001
|
Sepsis (%) | 150 (4.9) | 173 (4.5) | 323 (4.7) | 0.419 | 277 (6.7) | 214 (5.0) | 491 (5.8) |
0.001
|
In-hospital amputation (%) | 399 (13.0) | 280 (7.3) | 679 (9.8) | <0.001
| 1952 (47.5) | 1579 (36.7) | 3531 (42.0) | <0.001
|
In-hospital death (%) | 80 (2.6) | 154 (4.0) | 234 (3.4) |
0.002
| 300 (7.3) | 401 (9.3) | 701 (8.3) |
0.001
|
Complications and in-hospital outcome
Long-term outcome
Rutherford grade 5 | Rutherford grade 6 | |||||||
---|---|---|---|---|---|---|---|---|
Mortality | Amputation | Mortality | Amputation | |||||
HR (95% CI) | P | HR (95% CI) | P | HR (95% CI) | P | HR (95% CI) | P | |
Age | 1.05 (1.04–1.05) | <0.001
| 0.99 (0.99–1.00) |
0.010
| 1.05 (1.05–1.06) | <0.001
| 1.00 (1.00–1.00) | 0.951 |
Male gender | 1.13 (1.04–1.23) |
0.003
| 1.48 (1.34–1.63) | <0.001
| 1.14 (1.07–1.22) | <0.001
| 1.27 (1.20–1.35) | <0.001
|
Hypertension | 0.80 (0.74–0.86) | <0.001
| 0.91 (0.82–1.01) | 0.066 | 0.82 (0.77–0.88) | <0.001
| 0.93 (0.87–0.99) |
0.017
|
Obesity | 0.68 (0.57–0.82) | <0.001
| 0.79 (0.66–0.94) |
0.007
| 0.81 (0.70–0.93) |
0.002
| 0.96 (0.87–1.07) | 0.502 |
Dyslipidemia | 0.75 (0.68–0.82) | <0.001
| 0.96 (0.86–1.07) | 0.442 | 0.76 (0.70–0.83) | <0.001
| 0.85 (0.79–0.92) | <0.001
|
Smoking | 0.99 (0.81–1.20) | 0.896 | 0.91 (0.75–1.11) | 0.372 | 0.98 (0.84–1.14) | 0.804 | 0.81 (0.72–0.92) |
0.001
|
Diabetes | 0.95 (0.88–1.03) | 0.222 | 1.51 (1.38–1.67) | <0.001
| 0.92 (0.86–0.98) |
0.009
| 1.33 (1.25–1.41) | <0.001
|
CAD | 1.20 (1.10–1.31) | <0.001
| 1.04 (0.93–1.16) | 0.479 | 1.25 (1.17–1.34) | <0.001
| 0.98 (0.91–1.05) | 0.514 |
CHF | 1.63 (1.49–1.79) | <0.001
| 0.94 (0.82–1.08) | 0.410 | 1.50 (1.39–1.61) | <0.001
| 1.10 (1.02–1.19) |
0.012
|
CKD | 1.55 (1.43–1.68) | <0.001
| 1.33 (1.20–1.47) | <0.001
| 1.38 (1.30–1.47) | <0.001
| 0.98 (0.92–1.05) | 0.572 |
Malignancies | 1.73 (1.38–2.16) | <0.001
| 0.97 (0.68–1.37) | 0.855 | 1.93 (1.66–2.24) | <0.001
| 0.86 (0.72–1.03) | 0.106 |